PHARMACEUTICAL FORMULATION TO REDUCE INFLAMMATION OF BONES AND JOINT FRICTION WITH IMPROVED CARTILAGE QUALITY

摘要

This invention is based on an exclusive pharmaceutical formulation to reduce inflammation bones and joint friction with improve cartilage quality, comprising Glucosamine, MSM (Methyl Suphonil Methane), Taurine and RacemetMonin. The concentration of following ingredients are Glucosamine 500 mg/capsule, Methyl sulfonyl methane 25 mg/capsule, Taurine 500 mg/capsule and racemethionin 100 mg/capsule.